169 related articles for article (PubMed ID: 35390677)
1. Neuronal SH2B1 attenuates apoptosis in an MPTP mouse model of Parkinson's disease via promoting PLIN4 degradation.
Han X; Liu Y; Dai Y; Xu T; Hu Q; Yi X; Rui L; Hu G; Hu J
Redox Biol; 2022 Jun; 52():102308. PubMed ID: 35390677
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
3. Early B Cell Factor 3 (EBF3) attenuates Parkinson's disease through directly regulating contactin-associated protein-like 4 (CNTNAP4) transcription: An experimental study.
Hu W; Wang M; Sun G; Zhang L; Lu H
Cell Signal; 2024 Jun; 118():111139. PubMed ID: 38479556
[TBL] [Abstract][Full Text] [Related]
4. Impaired CBS-H
Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
Rani L; Ghosh B; Ahmad MH; Mondal AC
Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
[TBL] [Abstract][Full Text] [Related]
6. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
8. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
Ding H; Underwood R; Lavalley N; Yacoubian TA
Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
[TBL] [Abstract][Full Text] [Related]
10. Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson's Disease.
Qiao C; Zhang LX; Sun XY; Ding JH; Lu M; Hu G
Mol Neurobiol; 2017 Aug; 54(6):4292-4302. PubMed ID: 27339879
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
[TBL] [Abstract][Full Text] [Related]
12. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
13. DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease.
Kinugawa K; Monnet Y; Béchade C; Alvarez-Fischer D; Hirsch EC; Bessis A; Hunot S
J Neuroinflammation; 2013 Jul; 10():82. PubMed ID: 23844828
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
15. LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p.
Fan Y; Zhao X; Lu K; Cheng G
Brain Res Bull; 2020 Apr; 157():119-127. PubMed ID: 32057951
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP
Wu KC; Liou HH; Lee CY; Lin CJ
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389
[TBL] [Abstract][Full Text] [Related]
17. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
[TBL] [Abstract][Full Text] [Related]
18. RIPK1 inhibitor ameliorates the MPP
Liu J; Hu H; Wu B
Brain Res; 2021 Apr; 1757():147310. PubMed ID: 33524379
[TBL] [Abstract][Full Text] [Related]
19. Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease.
Boukhzar L; Hamieh A; Cartier D; Tanguy Y; Alsharif I; Castex M; Arabo A; El Hajji S; Bonnet JJ; Errami M; Falluel-Morel A; Chagraoui A; Lihrmann I; Anouar Y
Antioxid Redox Signal; 2016 Apr; 24(11):557-74. PubMed ID: 26866473
[TBL] [Abstract][Full Text] [Related]
20. PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.
Choi YJ; Kim DW; Shin MJ; Yeo HJ; Yeo EJ; Lee LR; Song Y; Kim DS; Han KH; Park J; Lee KW; Park JK; Eum WS; Choi SY
Molecules; 2021 Jun; 26(11):. PubMed ID: 34206041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
